Inhibition of the interleukin 6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) epigenetic feedback loop by OPG prevents the maintenance of epithelial-mesenchymal transition (EMT) and stemness features in breast cancer cells, which are essential for cancer progression and metastasis. Here, IL6 is linked to breast cancer.